Detalhe da pesquisa
1.
An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis.
Acta Derm Venereol
; 100(19): adv00344, 2020 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236124
2.
Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque Psoriasis: An Integrated Analysis of UNCOVER-2 and UNCOVER-3 Outcomes.
Acta Derm Venereol
; 99(11): 971-977, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31240322
3.
Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.
Hum Psychopharmacol
; 31(1): 53-63, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331440
4.
Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Am J Geriatr Psychiatry
; 21(8): 769-84, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23567397
5.
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S).
Dermatol Ther (Heidelb)
; 10(4): 663-670, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415575
6.
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
Clin Ther
; 31(3): 492-502, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19393840
7.
Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3.
J Dermatolog Treat
; 30(1): 19-26, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29726739
8.
Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies.
Dermatol Ther (Heidelb)
; 8(4): 621-637, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465321
9.
Growth hormone in combination with leuprorelin in pubertal children with idiopathic short stature.
Endocr Connect
; 7(5): 708-718, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669803
10.
Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being.
Neuropsychiatr Dis Treat
; 12: 2737-2743, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27822046
11.
A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients.
J Psychopharmacol
; 30(5): 444-58, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27005307
12.
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
CNS Drugs
; 30(4): 317-34, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055440
13.
Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
CNS Drugs
; 30(6): 541-58, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27224994
14.
A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation.
Neuropsychiatr Dis Treat
; 11: 1349-57, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26064053
15.
Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
J Diabetes Complications
; 28(5): 698-704, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24862108
16.
Individual residual symptoms and functional impairment in patients with depression.
Psychiatry Res
; 220(1-2): 258-62, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25149132
17.
Impact of pretreatment with antidepressants on the efficacy of duloxetine in terms of mood symptoms and functioning: an analysis of 15 pooled major depressive disorder studies.
Prim Care Companion CNS Disord
; 16(5)2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25667808
18.
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.
Neuropsychiatr Dis Treat
; 9: 1737-50, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24235837